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Background: Organelle remodeling processes are evolutionarily conserved and involved in cell functions during
development, aging, and cell death. Some endogenous and exogenous molecules can modulate these processes.
Docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid, has mainly been considered as a modulator
of plasma membrane fluidity in brain development and aging, while DHA’s role in organelle remodeling in specific
neural cell types at the ultrastructural level remains largely unexplored. DHA is notably incorporated into dynamic
organelles named lipid bodies (LBs). We hypothesized that DHA could attenuate the inflammatory response in
lipopolysaccharide (LPS)-activated microglia by remodeling LBs and altering their functional interplay with
mitochondria and other associated organelles.
Results: We used electron microscopy to analyze at high spatial resolution organelle changes in N9 microglial
cells exposed to the proinflammogen LPS, with or without DHA supplementation. Our results revealed that DHA
reverses several effects of LPS in organelles. In particular, a large number of very small and grouped LBs was
exclusively found in microglial cells exposed to DHA. In contrast, LBs in LPS-stimulated cells in the absence of
DHA were sparse and large. LBs formed in the presence of DHA were generally electron-dense, suggesting DHA
incorporation into these organelles. The accumulation of LBs in microglial cells from mouse and human was
confirmed in situ. In addition, DHA induced numerous contacts between LBs and mitochondria and reversed
the frequent disruption of mitochondrial integrity observed upon LPS stimulation. Dilation of the endoplasmic
reticulum lumen was also infrequent following DHA treatment, suggesting that DHA reduces oxidative stress
and protein misfolding. Lipidomic analysis in N9 microglial cells treated with DHA revealed an increase in
phosphatidylserine, indicating the role of this phospholipid in normalization and maintenance of physiological
membrane functions. This finding was supported by a marked reduction of microglial filopodia and endosome
number and significant reduction of LPS-induced phagocytosis.
Conclusions: DHA attenuates the inflammatory response in LPS-stimulated microglial cells by remodeling LBs
and altering their interplay with mitochondria and other associated organelles. Our findings point towards a
mechanism by which omega-3 DHA participates in organelle reorganization and contributes to the maintenance
of neural cell homeostasis.
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Docosahexaenoic acid (DHA, 22:6n3) is a member of
omega-3 polyunsaturated fatty acids. Its physical, che-
mical, and biological properties were extensively investi-
gated, but its mechanisms of action in neural cells are
still unclear since it exerts different biological activities
depending on the cell type and physiological or patho-
logical context [1–3]. Several studies suggest anti-
inflammatory and immunomodulatory properties of
omega-3 long chain polyunsaturated fatty acids inclu-
ding DHA [4]. DHA is proposed to be effective in pre-
venting or treating chronic inflammatory conditions that
comprise inflammatory bowel disease, rheumatoid arth-
ritis, and asthma, as well as neurodegenerative disorders
[1, 5–7]. DHA is a substrate for the synthesis of lipid
mediators such as resolvins, protectins, and maresins, all
of which have anti-inflammatory properties [8–10].
DHA is particularly retained and concentrated in the
nervous system, where it ameliorates neuronal circuit
integrity and plasticity [11] and hence learning and
memory functions [1]. A recent meta-analysis in human
suggests that DHA, alone or combined with another
member of omega-3 polyunsaturated fatty acids, eico-
sapentaenoic acid (EPA), contributes to improving
memory function in older adults with mild memory
complaints [12]. We hypothesize that DHA-induced
organelle remodeling in microglia activated by the proin-
flammogen lipopolysaccharide (LPS) contributes to the
preservation of microglial cellular functions.
At the cellular level, DHA is mainly incorporated into
cell membranes and lipid bodies (LBs). LBs are dynamic,
biological micelles composed of a lipophilic core that
mainly contain neutral lipids (cholesterol esters and tri-
glycerides) and a phospholipid monolayer surface with
numerous associated signaling proteins [13–17]. Among
these, the most investigated proteins are perilipins. Sev-
eral perilipins were found to be associated with different
sizes of LBs, playing a crucial role in the regulation of
LBs stability and biogenesis [18]. Stabilized LBs could
contribute to the maintenance of lipid homeostasis and
cell function, whereas inadequate surface protection
could lead to inadequate lipid compartmentalization
[19]. Large LBs are actively formed in vivo in several im-
mune cells during inflammation and constitute sites for
the synthesis and storage of various inflammatory medi-
ators [20]. An emerging view is that the remodeling of
LBs could represent an early biomarker of neuroinflam-
mation and modulator of neurodegenerative diseases. In
particular, perilipin 2 expression was found to be in-
creased in a time-dependent manner in activated N9
microglial cells and primary microglia, concomitantly
with the activation of c-Jun N-terminal kinase (JNK) and
the p38 MAPK stress signaling pathways [21–23]. Add-
itionally, it was recently shown that LBs accumulation inmicroglia and astrocytes, driven by mitochondrial de-
fects and increased oxidative stress in neurons, can pro-
mote neurodegeneration [24], but the mechanisms
involved are still undetermined.
Beneficial and detrimental contributions of microglia
to neuronal circuit integrity and plasticity are associated
with their phagocytic ability, depending on their
particular phenotype and nature of the phagocytosed
elements [25]. Phagocytosis is generally considered
beneficial since it eliminates dead cells and induces an
anti-inflammatory response. However, it can also acti-
vate respiratory bursts resulting in the generation of
reactive oxygen and nitrogen species [25]. Additionally,
microglia can eliminate viable neurons through “pha-
goptosis,” an endocytic program of cell death execution
[26]. During nervous system development, the phago-
cytosis of neurons and synaptic elements (pre-synaptic
axon terminals and post-synaptic dendritic spines) plays
a prominent role in the establishment of brain circuits
[27, 28]. In the adult brain, microglia further contribute
to maintaining homeostasis through their dynamic sur-
veillance of the parenchyma and to different processes
involved in brain plasticity [29–31].
LPS has been often used as a proinflammogen to
stimulate microglia and induce an inflammatory
response [32]. LPS was also used to determine the ef-
fectiveness of anti-inflammatory agents, alone or incor-
porated into nanodelivery systems [21, 22]. Our recent
investigations showed that DHA can attenuate micro-
glial dysfunction and disruption of neuronal circuit
integrity in organotypic hippocampal cultures exposed
to LPS [22]. In particular, DHA increased LB numbers
and prevented mitochondrial impairment in microglial
cells. These changes were associated with a reduced
loss of dendritic spines [22]. Nevertheless, due to the
limited resolution of confocal microscopy, we could not
observe structural changes in LBs and their relationship
with mitochondria. Dynamic remodeling of LBs in
microglia exposed to LPS, DHA, or both could have a
significant impact on LBs communication with associ-
ated organelles. Close apposition between LBs and
mitochondria could preserve mitochondrial health by
facilitating the coupling of triglyceride hydrolysis and
promote ATP production and contribute to an enrich-
ment of non-peroxidized cardiolipins in mitochondria
[33–35]. Cardiolipins are lipid components of mitochon-
dria mainly localized in their inner membranes. However,
they can be externalized and as such serve as signals for
mitophagy [34]. Peroxidized cardiolipins have deleterious
effects on mitochondrial functions [35–37].
The objective of this study was to characterize organ-
elle remodeling as a mode of DHA-induced neuroprotec-
tion in LPS-stimulated N9 microglial cells. Transmission
electron microscopy (TEM) was performed to analyze
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somes in LPS-stimulated microglia exposed to DHA.
High spatial resolution TEM enabled us to reveal
unexpected changes in LB organization and their
contacts with mitochondria and other associated
organelles under employed experimental conditions.
Organelle reorganization was particularly marked in
activated microglial cells treated with DHA, and it was
related to the regulation of inflammation biomarkers
and normalization of phagocytosis. The accumulation
of LBs in microglia in situ was also confirmed in
mouse and human. Furthermore, lipidomic analyses of
N9 microglial cells revealed that phosphatidyl serine
(PS) was markedly increased by DHA, suggesting its
contribution to the preservation of microglial cellular
functions. Collectively, our findings show that DHA
plays an important role in the remodeling of LBs and
associated organelles in cultured microglia, thereby
contributing to neural cell homeostasis.
Results
Our working hypothesis was that DHA attenuates the
inflammatory response in LPS-stimulated microglial
cells, through the remodeling of LBs and their interplay
with mitochondria and other associated organelles.
Remodeling of lipid bodies
Considering the limited resolution of confocal micros-
copy, we conducted TEM experiments to provide in-
sights into the combined effects of LPS and DHA on the
dynamic remodeling of LBs. Our ultrastructural analyses
were conducted at a DHA concentration of 50 μM, since
LPS added to the DHA-induced cytotoxicity at higher
concentrations. Annexin V binding was significantly
increased when N9 microglial cells were exposed to
100 μM DHA for 24 h. High DHA concentrations in-
duced some necrotic cell death in addition to apoptosis,
as revealed by propidium iodide-labeled nuclei and frag-
mented cells (Additional file 1: Figure S1A-C).
We characterized the organization of LBs in N9
microglial cells exposed to LPS proinflammogen stimu-
lation, with or without supplementation with DHA
(Fig. 1a–d). Two types of LBs were encountered across
our experimental conditions: lipid vacuoles delimited by
a bilayer and recognized by their irregular contours
and heterogeneous contents, as well as lipid “drop-
lets” or bodies (similar to those described in adipo-
cytes [38] and also found in non-adipocytes [39])
delimited by a monolayer and characterized by their
small size, the roundness of their profiles, and the
uniformity of their lipid contents [40, 41]. Microglial
accumulation of LBs showing various sizes and elec-
tron densities was confirmed in situ in C57Bl/6
mouse hippocampus and cerebral cortex (Fig. 2a–f,Additional file 2: Figure S2A), as well as in human
hippocampus (Additional file 2: Figure S2B, C and
Additional file 3).
Our analysis in N9 microglial cells revealed that LBs
mainly display ultrastructural features of lipid vacuoles
under control, LPS, or DHA conditions, while fewer
lipid vacuoles were observed in the combined presence
of LPS and DHA (Fig. 3a–e). Variations in the size of
these lipid vacuoles were noted, displaying smaller sizes
in the control condition, medium sizes in the DHA con-
dition, and larger sizes in the LPS condition (Fig. 3i),
which confirm the previous observations from confocal
microscopy. Additionally, the size of lipid vacuoles was
normalized by DHA treatment in the LPS condition
(Fig. 3i). Lipid droplets were rarely observed in the con-
trol or LPS conditions, where they invariably showed an
electron-lucent (clear) content (Fig. 3a, b). Treatment
with DHA greatly increased the number of lipid drop-
lets, which were generally small and often showing an
electron-dense (dark) content (Fig. 3c, g), suggesting the
incorporation of DHA having a high affinity for osmium
tetroxide, a lipid fixative used in our cell preparation for
electron microscopy [40].
The combined exposure to LPS and DHA further in-
creased the prevalence of lipid droplets in microglial cells
(Fig. 3d, g). These lipid droplets often displayed an
electron-dense content and were more often found in dir-
ect juxtaposition one with another upon DHA treatment
(Fig. 3h; contrary to the grouping of vacuoles which
remained unchanged; Fig. 3f). Interestingly, a large number
of very small and grouped LBs was seen only when micro-
glial cells were exposed to DHA and was detectable by
TEM and not by confocal microscopy (Fig. 3d). Overall,
these observations indicate that the increase in LBs size
and density that is observed with confocal microscopy upon
treatment with DHA is accompanied by LBs reorganization
and aggregation. This remodeling of LBs could be mediated
by the activation and phosphorylation of the mitogen-
activated protein kinase p38, as suggested previously [21,
22, 42], considering that activation of p38 and JNK stimu-
lates the formation of LBs in human monocytes [43].
Similarly, very small LBs were observed in situ in
mouse and human microglia (Fig. 2c–f and Additional
file 2: Figure S2B, C). The very small droplets were
often grouped and positioned close to each other and
sometimes juxtaposed very large lipofuscin granules
(Fig. 2c–f ) visible with immunogold that produces a
discrete precipitate, unmasking intracellular organelles
and lipidic inclusions contrary to immunoperoxidase
staining, which diffuses throughout the subcellular
compartments. Lipofuscin granules contain several spe-
cies of fatty acids [44], accumulate during oxidative
stress and aging [45], and could interfere with several
metabolic processes [46].
Fig. 1 Changes in microglial cell morphology and accumulation of lipid bodies following treatment with LPS, DHA, or a combination of LPS and
DHA. a In the control condition, microglial cell showing a typical morphology charactrized by few filopodia (arrowhead), lipid vacuoles (v), and
droplets (asterisk). g Golgi apparatus, er endoplasmic reticulum, m mitochondria. Vacuoles are recognized by their irregular contours and
heterogeneous contents. Droplets are characterized by the roundness of their profiles and uniformity of their contents. b Microglial cell in the LPS
condition with numerous filopodia and lipid vacuoles but only a few droplets. A phagocytic inclusion (in) identified as an accumulation of partially
digested membranes can also be seen. c Microglial cell exposed to DHA showing several filopodial extensions and an increased prevalence of lipid
vacuoles and droplets compared with microglial cell in the control and LPS conditions. In the presence of DHA, lipid droplets with an electron-lucent
(clear) or electron-dense (dark) content and grouped one to another are observed and become the most prevalent form of lipidic inclusion in the
combined presence of LPS and DHA (d)
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Mitochondria
LBs remodeling could influence their spatial relationship
with mitochondria and their ability to preserve mito-
chondrial function. Our electron microscopy analysis in
microglial cells confirmed that LBs and mitochondria
are in close proximity but we found no evidence for the
organelle fusion (Fig. 4a–d). In addition to close appo-
sition of LBs with mitochondria, TEM revealed diffe-
rences in the intimate relationships between lipid
vacuoles and mitochondria. In particular, few contacts
between mitochondria and lipid vacuoles were observed
in microglial cells under control conditions and with
LPS treatment (Fig. 4a, b). Treatment with DHA alone
resulted in direct contacts between LBs and mitochon-
dria (Fig. 4c), while a combined treatment with DHA
and LPS induced numerous direct contacts between the
two organelles (Fig. 4d).
Following exposure to LPS, the changes in LBs associ-
ation with mitochondria were accompanied by a frequentdisruption of mitochondrial integrity (Additional file 4:
Figure S3A–F). Microglial cells treated with LPS occa-
sionally contained mitochondria partially to completely
devoid of cristae and partially to completely devoid of a
double membrane, confirming our previous findings that
DHA rescues mitochondrial health [22]. In the presence
of LPS only, microglial cell mitochondria were also more
heterogeneous in size, varying from small to large, while
budding of smaller mitochondria from larger ones was
sometimes encountered (Additional file 4: Figure S3A–F),
indicating an increased remodeling which could be medi-
ated by the activation and phosphorylation of p38 [43].
Abnormalities in mitochondrial morphology are often
associated with peroxidation of cardiolipins, specific
mitochondrial lipids [47]. Biochemical and morphological
abnormalities in mitochondria lead to their functional
impairment.
For example, decreased mitochondrial membrane
potential is associated with the production of reactive
oxygen species [48, 49]. We measured the incorporation
Fig. 2 Lipid bodies observed in situ in adult mouse microglia. a Microglia (m) stained for IBA1 with immunoperoxidase that is observed in
direct juxtaposition with two neurons (n). A protruding process contains a cellular inclusion (in) and a large LB resembling a droplet, in the
hippocampus CA1 of an adult mouse (3 months old). b Inset showing at higher magnification the cellular inclusion, which contains an
accumulation of cellular membranes in the process of being digested and, the LB, which displays two electron densities suggesting different
lipid compositions. c Microglial cell (m) stained for IBA1 with immunogold that contains several lipidic inclusions, among which a group of
small lipid droplets (asterisk) juxtaposing two electron-dense profiles of lipofuscin granules (g), in the cerebral cortex of an adult mouse (3 months).
ma myelinated axon. d Inset showing at higher magnification the ultrastructural features and relationships between lipid vacuoles and lipofuscin
granules. e Microglial process (m) stained for IBA1 with immunogold, observed in the same mouse, exhibiting several additional examples of lipidic
inclusions. f Inset showing at higher magnification the inclusions: two profiles of lipofuscin granules surrounding an accumulation of very small lipid
droplets (asterisk) grouped one to another. Different shades of gray can be noted among the lipid bodies, suggesting that they contain different lipid
species. bv blood vessel
Tremblay et al. Journal of Neuroinflammation  (2016) 13:116 Page 5 of 18
Fig. 3 (See legend on next page.)
Tremblay et al. Journal of Neuroinflammation  (2016) 13:116 Page 6 of 18
(See figure on previous page.)
Fig. 3 High magnification of lipid bodies in microglial cells following treatment with LPS, DHA, or a combination of LPS and DHA. Few lipid
vacuoles (v) displaying irregular contours and frequent membranous contents are observed under control conditions (a). They become more
numerous following treatment with LPS (b) and even more following treatment with DHA (c). In the presence of DHA, droplets showing round
profiles and uniform lipid contents, often with a dark appearance (asterisk), also accumulate inside of the microglial cells (c). In the combined
presence of LPS and DHA, lipid vacuoles become infrequent. Instead, droplets either displaying a clear or a dark appearance, and generally
grouped one to another, become the most prevalent from of lipidic inclusion encountered (d). e–i Quantitative analysis of lipid vacuoles and
droplets in N9 microglial cells from the four experiments groups. e, g Average number of lipid vacuoles (e) or droplets (g) per N9 microglial
cell ± SEM. f, h Average proportion of these lipid vacuoles (f) or droplets (h) found within groups, i.e., in direct apposition with at least another
vacuole or droplet, ±SEM. Mixed groups were sometimes observed. i Average size of the lipid vacuoles in N9 microglial cells ± SEM. *p < 0.05,
**p < 0.01, and ***p < 0.001
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microglial mitochondria upon exposure to DHA (5–
50 μM DHA) for 1 to 24 h. DHA increased TMRE
incorporation in a dose- and time-dependent manner
suggesting enhancement of mitochondrial function
(Fig. 4e and Additional file 5: Figure S4A–B). This TMRE
incorporation was reduced in the presence of LPS, and
treatment with DHA normalized it (Additional file 5:
Figure S4A, B). DHA additionally decreased the fluores-
cence intensity of CM-H2DCFDA, a general indicator of
reactive oxygen species, both in the presence and ab-
sence of LPS, suggesting a reduction of oxidative stress
under basal and inflammatory conditions (Additional file
6: Figure S5). Reactive oxygen species cause damage to
DNA, proteins, and lipids, may result in a progressive
loss of cellular functions, and lead to apoptosis and vari-
ous pathological conditions.
Endoplasmic reticulum
LBs have been shown to interact with the endoplasmic
reticulum (ER) across a variety of mammalian cell lines
[14, 16]. Nevertheless, the consequences of LBs remodel-
ing on their association with the ER are still undeter-
mined. Here, we used TEM analysis to provide insights
into the effects of DHA treatment on the interplay
between LBs and the ER in microglial cells. Our analysis
revealed only few focal contacts between lipid vacuoles
and stretches of ER in the control and LPS-treated cells
(Fig. 5a–d). Treatment with DHA changed this associ-
ation. In particular, the stretches of ER were more often
observed in close proximity with the LBs, whether dis-
playing a clear or dark content. The most striking
change was observed in microglial cells exposed to LPS
and DHA. Their stretches of ER ran parallel to the LBs
and intermingled over long distances (Fig. 5d), sug-
gesting the occurrence of functional interactions. In
addition, dilation of the ER lumen, which is the best
characterized sign of oxidative stress at the ultrastruc-
tural level [50], was observed in the LPS-only condition
but seldom in other treatment groups. The beneficial
effects of DHA on ER health are supported by the pre-
vious evidence that DHA contributes to preventing
oxidative stress through the restoration of calciumhomeostasis in the ER lumen, as required for the proper
folding of proteins [51].
Our data from mass spectrometric quantification of
microglial cells exposed to LPS and/or DHA show that
free fatty acids and triglycerides are enhanced with
exposure to LPS but not with DHA whereas PS is sig-
nificantly increased in response to DHA (Fig. 6a–c). PS
is the most abundant negatively charged phospholipid in
eukaryotic membrane [49]. It also plays a role in signal
transduction [50]. Concentrations of generally more
abundant phospholipid membrane constituents (phos-
phatidylcholine, phosphatidylethanolamine, and phos-
phatidylinositides) were not altered in DHA-treated
cells. Interestingly, there was a significant increase in
phagocytosis in microglial cells exposed to DHA alone
contrary to the bovine serum albumin (BSA) carrier
(Fig. 7a, b and Additional file 7: Figure S6); correlating
with increased intracellular PS concentrations. This
effect was concentration-dependent showing maximal
effects at 50 μM, and differences relative to untreated
controls were measured as early as 6 h after DHA treat-
ment (50 μM DHA, Fig. 7a, b). Cell treatment with
DHA (5–50 μM) for 6 h only did not cause any signifi-
cant cell death (Additional file 1: Figure S1A–C). An-
other microglial function affected by DHA treatment was
the release of pro-inflammatory cytokines. Both TNFα and
IL-1β were significantly increased with LPS treatment and
reduced with DHA (Fig. 6d, e). Collectively, these findings
suggest that proper incorporation of PS into the inner
leaflets of cellular membranes contributes to the intracel-
lular signaling required for the maintenance of cellular in-
tegrity and health [52]. In contrast, PS exposed to the cell
surface plays a critical role in macrophage recognition of
neural cells to be internalized [26, 53].
Endosomes
Large endosomes containing an accumulation of hetero-
geneous contents were also mainly observed in LPS-
stimulated microglial cells, sometimes in direct contact
with LBs (see Fig. 1b for an example). These elements
displayed various signs of digestion, indicating an on-
going state of degradation (Fig. 1 and Additional file 4:
Figure S3E, F). Within the endosomes, membranes
Fig. 4 High magnification of direct contacts between lipid bodies and mitochondria in microglial cells, as well as changes in mitochondrial
membrane potential following treatment with LPS, DHA, or a combination of LPS and DHA. Few contacts between mitochondria (m) and lipid
vacuoles (v) are observed in the control condition (a), and similar observations can be made following treatment with LPS (b). In the presence of
DHA (c) and combined presence of LPS and DHA (d), however, direct contacts between mitochondria and lipid bodies, especially lipid vacuoles
following DHA treatment and lipid droplets (asterisk) following LPS and DHA treatment, become more prevalent. e Changes in mitochondrial
membrane potential of N9 microglial cells treated with DHA (5–50 μM) for 24 h. Following treatment, cells were incubated with TMRE (50 nM) for
20 min, after which the media was refreshed and cells were imaged under a fluorescent microscope. Four fields were imaged per treatment, and
two cells were imaged per field. Shown are average fold increase in intracellular relative fluorescence intensities ± SEM as compared to untreated
control (set to 1) from three independent experiments. Cells imaged in the absence of TMRE and cells treated with FCCP were negative
controls. *p < 0.01
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Fig. 5 Relationship between lipid bodies and endoplasmic reticulum cisternae in microglial cells at ultrastructural level following treatment with
LPS, DHA, or a combination of LPS and DHA. Focal contacts between lipid vacuoles (v) and endoplasmic reticulum cisternae (er) are observed
(arrowheads) under control conditions (a), as well as following treatment with LPS (b). Following treatment with DHA (c) or treatment with both
LPS and DHA (d), stretches of endoplasmic reticulum cisternae are often observed in close proximity (arrowhead) with the lipid droplets (asterisks)
showing a clear or a dark appearance. Long stretches of endoplasmic reticulum cisternae directly touching and surrounding the lipid droplets are
particularly observed in the combined presence of LPS and DHA (d)
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bodies, which are lysosomal organelles containing mul-
tiple concentric membrane layers, as found in various cell
types where their principal functions are storage and
secretion of lipids [54], were also often encountered. The
autophagic or phagocytic origin of these endosomes is un-
determined, especially considering that primary microglia
and N9 cells can phagocytose various types of debris, in
addition to apoptotic cells in culture. Multilamellar bodies
have been shown to be generated through autophagy [55],
a catabolic process aimed at recycling cellular components
and damaged organelles that is especially triggered by
exposure to reactive oxygen and nitrogen species [56].
Consequences of organelle remodeling on microglial cell
functions
Our recent studies showed a marked loss of dendritic
spines in hippocampal CA1 region when hyperactivemicroglial cells produced enhanced amounts of cyto-
kines (including IL-6 and TNFα) and nitric oxide (NO)
[57], suggesting that microglial phagocytosis could be
implicated in their elimination. In these studies, how-
ever, no detailed information on organelle remodeling
was provided because of the limited resolution of con-
focal microscopy.
Concentration- and time-dependent experiments
with LPS-stimulated N9 microglial cells revealed a re-
markable increase in phagocytic activity within 6 h of
treatment (Fig. 7a). Low concentrations of DHA (10
and 25 μM) in the presence of LPS also increased
phagocytosis, whereas higher concentrations of DHA
(50 μM) attenuated it (Fig. 7b). At the ultrastructural
level, this excessive phagocytosis triggered by LPS is
supported by the observation that filopodia protruding
from N9 microglial cells were most abundant following
LPS treatment (Fig. 1b). Filopodia are considered to be
Fig. 6 DHA-induced changes in functional biomarkers in activated microglial cells. Mass spectrometric analyses of free fatty acids (FFA, a)
and triglycerides (TG, b) did not reveal marked changes in the content of these lipids in N9 microglial cells treated with DHA. In contrast,
phosphatidyl serine (PS) was significantly increased (c). The amount of released proinflmmatory cytokines (d–e) was moderately but
significantly reduced with DHA supplemented in the medium. *p < 0.05, **p < 0.01, and ***p < 0.001. All measurements were performed
in triplicate samples in at least two independent experiments
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lamellipodia. They can act as phagocytic tentacles for
the engulfment of tissue components by macrophages
[58] and microglia [59, 60]. Our functional data
together with the electron microscopic analyses of
organelle remodeling support the notion that DHA
reduces the exacerbated microglial phagocytosis and
that restoration of neural cell homeostasis involves a
complex dynamic microglial reorganization globally
detectable by live cell imaging and at the ultrastruc-
tural level [32].Fig. 7 DHA-induced changes in microglial cell phagocytosis. a–b Effect of
LPS. N9 microglial cell were cultured for 6 h (a) in the presence or absence
or absence of DHA (10, 25, 50 μM) and LPS (100 ng/mL). FluoSpheres (106
Cells were fixed using 4 % paraformaldehyde and labeled with Hoechst 33
under a fluorescent microscope. The number of FluoSpheres per cell was c
containing FluoSpheres ± SEM from three independent experiments. *p < 0Discussion
The studies show DHA-induced structural organelle
remodeling and associated improved functions in the
proinflammogen-stimulated mouse N9 microglial cells.
Morphological changes of organelles proposed to inte-
ract with LBs were revealed using TEM. DHA supple-
mentation increased the prevalence of direct contacts
between LBs and mitochondria. DHA also rescued mito-
chondria from loss of cristae and functional integrity
induced by LPS treatment. Based on the data from these
and earlier studies, a working model of organelleDHA on N9 mouse microglial phagocytic activity with and without
of DHA (50 μM) and LPS (100 ng/mL) or for 24 h (b) in the presence
particles/mL) were added to the cells 3 h before the end of treatment.
258 (10 μM, 10 min). Cells were mounted on glass slides and imaged
ounted manually. Shown are average percentages of total cells
.01
Fig. 8 A model of DHA-induced organelle remodeling in LPS-stimulated microglial cells. Microglia under normal physiological conditions are
in the surveying state with constantly extending-retracting filopodia and such microglia have only a few lipid bodies (surveying microglia,
physiological conditions). Upon exposure to pro-inflammatory agents (e.g., lipopolysaccharide (LPS) produced by Gram-negative bacteria)
microglia become activated and show transiently an enhanced phagocytosis (e.g., of fluorescent beads or cellular fragments). Such highly
activated state is characterized by large number of filopodia and small number of enlarged lipid bodies together with impaired mitochondrial
morphology and function. During aging and protracted LPS stimulation, microglial cells gradually lose their protective phagocytic ability. DHA
in LPS-hyperactivated microglia normalize the number of filopodia, morphology, and function of mitochondria and lipid bodies thereby
maintaining their homeostasis. A particular feature of DHA-induced organelle remodeling is fragmentation of excessively large lipid bodies
and facilitation of their association with other organelles (e.g., mitochondria)
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is proposed (Fig. 8).
DHA treatment induces LBs remodeling: the apparent
“large” LBs previously detected by confocal microscopy
are actually a conglomerate of many small ones. The
relevance of this finding is that the mobility and recruit-
ment of proteins to the surface of LBs depends on LB
size and is markedly different between the small and big
ones [20]. In consequence, the existence of many small
LBs with DHA treatment could modify intracellular pro-
tein trafficking and docking in microglia and likely in
other cell types. The cell type-dependent LB formation
was recently shown to play a role in neurodegeneration
[23, 24]. A remarkable heterogeneity of LBs and their
reversibility was reported in hepatocytes [49] and in vivo
in adipocytes [61]. It is conceivable that the heterogen-
eity is necessary to achieve cell protection by engaging
only certain populations of LBs. This could explain the
protective role of LBs in DHA-treated cells.
Most of PS molecules are located within the inner
cytoplasmic membrane in healthy cells under normal
physiological conditions. Soluble cations, polycationsand proteins with clustered positively charged domains
are attracted to the PS negative charges in the inner leaf-
lets. Such PS transmembrane distribution has impli-
cations in PS-mediated intracellular signaling. For
instance, when some pathogens cause depletion of PS
from phagosomes, the Src tyrosine kinase is also lost
[62]. Another example is Akt, a signaling protein with
pleckstrin homology domain which interacts with PS.
DHA engages signaling pathway via PI3K and Akt acti-
vation. Basic residues of Akt are involved in binding to
PS and could contribute to DHA-induced Akt activation
[63]. We propose that PS species are rapidly transported
from the ER to the plasma and endosomal membranes
where they may cause specific changes in the membrane
biophysical properties (such as in fluidity, thickness,
protein-protein, and protein-lipid interactions). This in
turn, could attenuate the signaling promoted by LPS-
and/or age-related neuroinflammation and neurodege-
neration. Moreover, the molecular species of PS induced
by DHA may also facilitate the binding of anti-
inflammatory cytokines (such as IL-10) to the membrane
and its stabilization.
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kines IL-1β and promotes resolution of inflammation
[8]. The mechanisms underlying these protective pro-
cesses are not fully understood. We propose that LBs
fragmentation can contribute to these protective effects
by favorable lipid segregation, protein recruitment, and
increased intracellular mobility. LBs were shown to
sequester polyunsaturated fatty acids away from plasma
membranes, thereby shielding these lipids from harmful
peroxidation [48]. This is especially relevant under
conditions of oxidative stress where exogenous supply of
DHA can prevent or at least reduce an overall risk of
lipotoxicity (e.g., in type 2 diabetes [64]). In addition,
DHA-derived resolvin D1 was reported to reduce ER
stress-induced apoptosis in hepatic cells [65] and resol-
vin D1 and E1 to decrease LPS-induced TNFα, IL-6, and
IL-1β gene expressions in cultured microglial cells.
These findings suggest resolution of cellular inflamma-
tory activity [66]. In macrophages, DHA also decreased
the ratio of pro-inflammatory leukotriene B4 to prore-
solving lipoxin A4, thereby tempering inflammation [67].
LPS-induced mitochondrial defects and increased
oxidative stress in neurons could be a missing link
between oxidative stress and inflammation leading to
neurodegeneration [24]. Formation of excessively large
LBs and release of TNFα, IL-1β, and NO from LPS-
stimulated N9 microglial cells could exacerbate
mitochondrial dysfunction and ER stress in a cell-
autonomous or non-autonomous manner. Indeed, an
interesting heterogeneity between microglial cells was
observed in our cultures. For instance, some LPS-
stimulated N9 microglial cells were completely devoid
of LBs, even when they were directly juxtaposed to
microglial cells containing many LBs (see Additional
file 4: Figure S3A for an example). Considering that our
TEM studies captured the cells at one time point, time
lapse experiments by employing super-resolution mi-
croscopy are required to establish the intercellular
communication and possible LBs transfer from one cell
to another. Organelle heterogeneity and remodeling
was also observed with mitochondria, ER, and autopha-
gic vacuoles, between cells, and between different or-
ganelles of individual cells. This cellular heterogeneity
could be in part explained by different stages in cell
cycle. For example, we have evidence for nuclear bud-
ding and fragmentation, suggesting an ongoing mitosis
and proliferation in a subset of N9 microglial cells
exposed to LPS (Additional file 8: Figure S7).
LPS- and DHA-induced organelle remodeling, regula-
tion of cytokine production, and phagocytosis are not
necessarily mutually exclusive. For example, excess of
pro-inflammatory cytokines production induces LBs
formation. Size and composition of LBs can influence
phagocytosis. Dysregulated phagocytosis can promotecytokine production, and cytokines can modify mito-
chondrial and LBs remodeling. It was shown that
DHA effects are time- and concentration-dependent
[22, 68, 69]. Similarly, LPS-induced microglial activa-
tion is time- and concentration-dependent [21]. Our
findings at 24 h suggest that DHA has attenuated pro-
inflammatory cytokine production, moving microglia
towards many of the M2-like states accompanied by
changes in their functional status, including the ability
to phagocytose. Excessive and defective phagocytosis
could lead to “frustrated resolution” and abnormal
remodeling of several organelles, including LBs and
mitochondria [70]. We suggest that organelle remo-
deling in association with increased pro-inflammatory
cytokine and ROS production induced by LPS are
disrupting homeostasis, which in vivo could contribute
to CNS impairments during aging. Adequate DHA
concentrations are essential for the maintenance of
homeostasis of the CNS. Each tissue and even cell type
likely requires an optimal DHA concentration to
maintain a balance between cytokine production and
elimination (phagocytosis) of damaged organelles or
misfolded and aggregated proteins. DHA concentra-
tions in our studies were within the concentration
range used by others [68]. The DHA metabolite resol-
vin D1 (RvD1) markedly promotes resolution of in-
flammation, macrophage polarization towards M2-like
phenotypes and promotes nonphlogistic phagocytosis
in macrophages [71]. Data from our current studies
and those by others [11, 72] suggest that DHA and its
metabolite RvD1 are desirable endogenous products
mediating resolution. Resolvin D1 upregulates several
micro RNAs (miRNAs; e.g., miR-146, miR-219, miR-
208) that are involved in NFκB and IL-10 expression
in resolution. Fullerton and Gilroy provide a current
view on the key players and factors that regulate in-
flammation and resolution, highlighting the efforts to
target pro-resolution pathways in diseases involving
inflammation [70]. Clearly, it is not sufficient to
achieve full resolution with only one “pro-resolution”
drug. Components of the resolution process include
organelle remodeling, homeostasis of pro- and anti-
inflammatory cytokines, and functions of microglia,
one of which is phagocytosis. Phagocytosis is a house-
keeping process in many cells that can be induced by
an acute exposure to LPS. Some studies show that the
LPS derivative monophosphoryl lipid A (MPL) induces
microglial phagocytosis in the absence of inflamma-
tion [73]. Interestingly, inhibition of microglial phago-
cytosis has been shown to prevent inflammatory
neuronal death [74] and synaptic loss in aging and
Alzheimer’s disease in vivo [75, 76].
Collectively, organelle remodeling as we observed in
microglial cells in culture likely occurs in vivo in animals
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conditions [29, 77] could contribute to synaptic loss and
cognitive impairment [78, 79]. The loss of synapses has
recently emerged as the best pathological correlate of
cognitive decline during aging and neurodegeneration
[80–82]. Recent genome-wide association studies have
linked polymorphisms in inflammation-related genes to
increased risk for Alzheimer’s disease, supporting the
conclusion that inflammation can be a causative factor
in the disease pathology [83]. Interestingly, in a mouse
model of accelerated aging where only neurons undergo
DNA damage (accompanied by oxidative stress), micro-
glia display an exaggerated response to LPS in terms of
pro-inflammatory cytokines and reactive oxygen spe-
cies production, as well as phagocytosis [84, 85]. An
exacerbated microglial phagocytosis of synaptic ele-
ments was recently observed in a mouse model of
chronic unpredictable stress [86]. Chronic stress is
well known to accelerate aging, predispose and
exacerbate progression and symptoms in neurodege-
nerative diseases [40, 87].
Conclusions
Results presented in this study suggest that DHA
supplementation contributes to the preservation of
microglial cell functions by inducing remodeling of
their LBs and their direct contacts with mitochondria
displaying increased ultrastructural integrity and inter-
mingling with ER cisternae showing reduced lumen
dilation. DHA supplementation also increases the
levels of PS and modulates phagocytosis. It will be
important in future studies to determine the time-
course of DHA actions on microglia in vivo [88] and
their functional relevance to stress resilience, healthy
aging, and cognitive improvement in patients suffering
from neuropsychiatric and neurodegenerative diseases.
Methods
Animals
All experiments were approved and performed under
the guidelines of the Institutional animal ethics com-
mittees, in conformity with the Canadian Council on
Animal Care guidelines as administered by the Animal
Care Committee of Université Laval. The animals were
housed under a 12-h light-dark cycle at 22–25 °C with
free access to food and water. Three-month-old (n = 4)
male mice on a C57Bl/6 background were examined in
this study for the purpose of validating microglial accu-
mulation of LBs observed in vitro. They were anesthe-
tized with sodium pentobarbital (80 mg/kg, i.p.) and
perfused through the aortic arch with 3.5 % acrolein
followed by 4 % paraformaldehyde. Transverse sections
of the brain (50-μm thick) were cut in sodium phosphate
buffer (PBS; 50 mM at pH 7.4) using a vibratome [89].Brain section staining and processing for electron
microscopy
Sections were washed in PBS, quenched with 0.3 %
H2O2 in PBS for 5 min and then with 0.1 % NaBH4 for
30 min at room temperature (RT), washed in Tris-
buffered saline (TBS; 50 mM at pH 7.4) containing
0.01 % Triton X100, and processed freely floating for im-
munostaining. Briefly, sections were pre-incubated for
1 h at RT in a blocking solution of TBS containing 10 %
fetal bovine serum, 3 % bovine serum albumin, and
0.01 % Triton X100. They were incubated overnight at
4 °C in rabbit anti-IBA1 antibody (1:1,000 in blocking
solution; Wako Pure Chemical Industries) and rinsed in
TBS. For immunoperoxidase staining, the sections were
then incubated for 1.5 h at RT in goat anti-rabbit IgGs
conjugated to biotin (1:200 in blocking solution; Jackson
Immunoresearch) and for 1 h with A and B reagents of
the ABC Vectastain system (1:100 in TBS; Vector La-
boratories). The labeling was revealed using diaminoben-
zidine (DAB; 0.05 %) and hydrogen peroxide (0.015 %)
in TBS for 5 min. For immunogold staining, the sections
were incubated with goat anti-rabbit IgGs conjugated to
1.4-nm immunogold (1:50 in blocking solution; Nano-
probes) in TBS overnight at 4 °C. They were rinsed in
TBS, then washed twice in 3 % sodium acetate in water.
The labeling was revealed using a silver enhancement kit
(HQ Silver, Nanoprobes) for 90 seconds at RT. After-
wards, the sections were post-fixed flat in 1 % osmium
tetroxide and dehydrated in ascending concentrations of
ethanol. They were treated with propylene oxide and
then impregnated in Durcupan resin (EMS) overnight at
RT. After mounting between ACLAR embedding films
(EMS), they were cured at 55 °C for 72 h. Areas of inter-
est (ventral hippocampus CA1 or parietal association
areas of the cerebral cortex) were excised from the em-
bedding films and glued on resin blocks.
N9 microglial cells
N9 microglial cells (provided by Dr. Seguela, Montreal
Neurological Institute, Montreal) were cultured in
Iscove’s Modified Dulbecco’s Medium (Invitrogen)
supplemented with 5 % (v/v) fetal bovine serum (FBS,
Invitrogen) and 1 % (v/v) penicillin-streptomycin
(Invitrogen). Cells were seeded 24 h prior to treatment/
media change according to the appropriate density for
the indicated assay (lower density for imaging and higher
density for biochemical assays). They were maintained at
37 °C with 5 % CO2 and >95 % relative humidity.
DHA/BSA complex preparation
DHA/BSA complex (hereafter referred to as DHA treat-
ment) was prepared by adding 25 mg of DHA (Nu-
Check Prep) to ~20 ml of fatty acid-free BSA solution
(5 %w/v, in KRBH buffer; Sigma-Aldrich). The DHA/
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the incubation, the pH of the solution was adjusted
to 7.4 and the solution was filtered through a 0.22-
μm filter. Non-esterified DHA concentration in the
solution was determined with the NEFA C method kit
(Wako). The final molar ratio of DHA to BSA was
approximately 6:1. Aliquots of the stock solution were
flushed with argon to prevent oxidation of DHA and
were stored at −80 °C. In addition, the presence of
BSA was controlled for in those cultures that did not
receive the DHA treatment.
Cells treatment, fixation, and processing for electron
microscopy
Cells were treated with DHA (50 μM) with or without
LPS (100 ng/ml) for 24 h. The LPS was extracted from
Escherichia coli of serotype 0111:B4 (Sigma-Aldrich).
For control experiments, cells were treated with bovine
serum albumin (BSA) at concentrations equivalent to
that contained in 50 μM DHA. All chemicals for elec-
tron microscopy (paraformaldehyde (16 %; electron mi-
croscopy grade), glutaraldehyde (25 %; electron
microscopy grade), uranyl acetate, and osmium tetrox-
ide) were purchased from Electron Microscopy Sciences
(Fort Washington, PA). Other chemicals were purchased
from Sigma (St. Louis MO). N9 cells were seeded in
Chamber slides (Lab Tek chamber slides, eight wells per
slide Permanox slides, Nunc Inc. Naperville Illinois,
USA). Ten thousand cells per square centimeter were
grown on surfaces coated with poly D-lysine. After 24-h
exposure to the treatments, cell culture medium was re-
moved and replaced with the fixation buffer consisting
of 1.5 % paraformaldehyde and 1.5 % glutaraldehyde in
0.2 M cacodylate buffer (pH 7.4). Cells were fixed for
1 h. Following fixation, the cells were carefully washed
with 0.1 M cacodylate washing buffer. The washing was
repeated three times and cells were post-fixed in 1 % os-
mium tetroxide. This step was followed by multiple
washing in cacodylate buffer; cells were dehydrated and
embedded in epon.
Ultrathin sectioning, TEM imaging, and LB analysis
For studies on brain sections, 70-nm sections containing
the ventral hippocampus CA1 radiatum or parietal asso-
ciation areas of the cerebral cortex were generated with
a Leica UC7 ultramicrotome. Images were acquired
using a FEI Tecnai Spirit G2 microscope equipped with
an ORCA-HR digital camera (10 MP; Hamamatsu) ope-
rating at an accelerated volatage of 80 kV. For studies
involving N9 microglial cells, 100-nm sections were cut
using an Ultracut E-ultramicrotome. Images were ac-
quired using a JOEL JEM-2000FX instrument operating
at 80 kV. A minimum of 10 cells per experiment were
imaged randomly and analyzed qualitatively, with theexperimenters blinded to the treatments during imaging
and analysis. A semi-quantitative code (+, ++, +++) was
used to compare the prevalence of direct contacts
between lipid vacuoles or droplets with mitochondria
and ER stretches, mitochondrial alterations, and ER dila-
tion, as well the prevalence of filopodia and phagocytic
inclusions across experimental conditions. For quantita-
tive analysis, the number of lipid vacuoles and lipid
droplets per cell, and their prevalence found within
groups (of 2+ vacuoles or droplets) was determined in
the four experimental groups. In addition, 50 randomly
selected lipid vacuoles per experimental group were
traced with the freehand selection tool in ImageJ, and
their area was measured.
Lipidomic analysis
Lipid analysis was performed as previously reported
[90]; prior to lipid extraction, internal standards were
added corresponding to each lipid class, then lipids were
extracted from whole cells by a modified Bligh and Dyer
[91] method; samples were dried under nitrogen then re-
suspended in chloroform. Immediately prior to injection,
the extracted lipids were combined with 2:1 methanol/
chloroform with 0.1 % (v/v) ammonium hydroxide. This
was injected directly into a Q-TOF 2 mass spectrometer
(Waters, Milford, MA) using a nano-esi spray source at
1 μl/min. Spectra were obtained in positive-ion mode
(PC +H+, TAG+NH4+) and negative-ion mode (FFA-H+,
PA-H+, PE-H+, PG-H+, PI-H+, PS-H+, CL-2H+). Ac-
quired spectra were centroided using the Masslynx
software then deconvoluted and deisotoped with excel
macros. In our experiments, N9 microglial cells were
subjected to lipid extraction followed by ESI-MS to de-
termine acyl chain composition at 0, 3, 9, and 24 h after
treatment. Results shown in Fig. 7 are those obtained
24 h after treatment. Control cells were only exposed to
BSA in the medium equivalent to the concentration
with DHA bound to BSA.
Phagocytic activity
To measure the extent of phagocytic activity in LPS-
activated microglia, N9 microglial cells were treated with
fluorescent polystyrene microbeads (FluoSpheres) mea-
suring 1 μm in diameter (Invitrogen #F13083, ex/em =
580/605 nm). Cells were treated with DHA (10–50 μM)
with or without LPS (100 ng/ml) for 6 or 24 h. The LPS
was extracted from E. coli of serotype 0111:B4 (Sigma-
Aldrich). For control experiments, cells were treated
with BSA at concentrations equivalent to that contained
in 25 or 50 μM DHA. Seeding flasks used are 75-cm2
cell culture flasks (Sarstedt). FluoSpheres were added
during the last 3 h of treatment at a concentration of
1 × 106 particles/mL. Cells were washed and fixed in 4 %
paraformaldehyde, labeled with Hoechst 33258 (10 μM,
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fluorescence microscope. Four fields were imaged per
treatment, and a minimum of 20 cells were imaged per
field. The number of cells with internalized FluoSpheres
was counted.
Cytokine measurements
Concentrations of TNFα and IL-1β released from un-
treated (control) and treated (LPS (100 ng/mL), DHA
(50 μM) and DHA + LPS) microglial cells were measured
using ELISA (Biolegend). Following treatments (24 h),
the samples were appropriately diluted and assessed ac-
cording to the manufacturer’s protocol. Standard curves
were prepared in duplicates for each experiment, and
cytokine concentration was calculated from the linear
portions of these standard curves as reference. We opted
to express increases in TNFα and IL-1β relative to the
control values (untreated cells) because these ratios were
very consistent and reproducible between repeated ex-
periments. In contrast, the absolute baseline values were
dependent on the cell number in three different experi-
ments. On average, the baseline values for TNFα were
within low nanomolar range (0.2 to 0.3 ng/mL), whereas
the baseline concentrations of IL-1β were much lower
picomolar range (20–25 pg/mL).
Mitochondrial membrane potential
N9 microglial cells were exposed to DHA (5–50 μM) for
24 h. For 6-h treatments, the cells were exposed to DHA
(50 μM) in the presence or absence of LPS (0.1 μg/mL).
Following treatment, the cells were incubated with tetra-
methylrhodamine ethyl ester (TMRE, Thermo Fisher,
50 nM) for 20 min, after which the media was refreshed
and cells were imaged under a fluorescence microscope.
Four fields were imaged per treatment. Intracellular
fluorescence was analyzed using ImageJ.
Cell viability assays
N9 microglial cell death was measured using the Alexa
Fluor 488 Annexin V/Dead Cell Apoptosis Kit (Thermo
Fisher), according to the recommendations of the manu-
facturer. Cells were treated with increasing concentra-
tions of DHA (5, 25, 50, 100 μM) in the presence or
absence of LPS (0.1 μg/mL) for 24 h, then labeled with
Hoechst 33258 (10 μM), Alexa 488-labeled Annexin
V and propidium iodide for 15 min. Cells were im-
aged using a high-throughput fluorescence microscope
(Operetta, Perkin Elmer). Five fields were imaged per
well, and cells were analyzed using the Columbus
software (Perkin Elmer). Cell viability measured by
cell counting was performed following treatment with
increasing concentrations of DHA (5, 25, 50, 100 μM)
in the presence or absence of LPS (0.1 μg/mL) for
24 h. Cells were then labeled with Hoechst 33258(10 μM, 10 min) and imaged using a high-throughput
fluorescence microscope. Five fields were imaged per
well, and cell counting was done in Columbus.
Oxidative stress assay
N9 microglial oxidative stress was measured using the re-
active oxygen species indicator CM-H2DCFDA (Thermo
Fisher). Cells were loaded with CM-H2DCFDA (10 μM,
30 min), then exposed to increasing concentrations of
DHA (10, 25, 50 μM) in the presence or absence of LPS
(0.1 μg/mL) for 1 h. Hydrogen peroxide (20 μM) was
included as a positive control. Following treatment, intra-
cellular fluorescence was imaged in live cells using a
fluorescence microscope. Four fields were imaged per
treatment, and 30 cells were analyzed per field.
Statistical analyses
All experiments were performed at least twice and all
samples were analyzed in triplicates. Data are expressed
as mean ± SEM and analyzed by ANOVA using Tukey’s
and Dunnett’s post hoc test for multiple comparisons. Sig-
nificant differences are indicated by *p < 0.05, **p < 0.01,
and ***p < 0.001.
Additional files
Additional file 1: Figure S1. Viability of microglial cells exposed to
DHA treatment. A–B. Viability of N9 microglial cells in response to DHA
(5–100 μM) after 24 h, in the presence or absence of LPS (100 ng/mL).
Following treatment, cells were labeled with Hoechst 33258 and
incubated with Alexa 488-labeled Annexin V (A) or propidium iodide
(B) for 15 min, after which they were imaged under a high-throughput
fluorescence microscope. Five fields were imaged per well, and cells
were analyzed using the Columbus software. Shown are mean percent-
ages of total cells positive for Annexin V or propidium iodide ± SEM from
three independent experiments. *p < 0.01. C. Viability of N9 microglial cells
treated with DHA (5–100 μM) as determined by cell counting after 24 h, in
the presence or absence of LPS (100 ng/mL). Following
treatment, cells were labeled with Hoechst 33258 and imaged under a
high-throughput fluorescence microscope. Five fields were imaged per
well, and three wells were included per treatment. The number of
nuclei was counted using the Columbus software. Shown are mean
percentage values ± SEM as compared to the untreated controls from
three independent experiments. *p < 0.01. (TIF 2392 kb)
Additional file 2: Figure S2. Microglial accumulation of lipid vacuoles
in aged mouse and human hippocampus. A. Microglia (m) stained for
IBA1 with immunoperoxidase showing an accumulation of LBs and
lipofuscin granules, various signs of oxidative stress (e.g., dilation of the
endoplasmic reticulum; er), as well as direct contacts with dendritic
spines (s) and axon terminals (t), in the hippocampus CA1 of an aged
mouse (20 months). B. We also initiated studies with human brain to
establish if there are similar organelle remodeling processes in the
human hippocampus. The key observation is that human microglia, and
especially those found nearby blood vessels which are considered to be
more active than parenchymal microglia, accumulate lipid droplets of
various sizes and electron densities. Example of microglia stained for IBA1
with immunoperoxidase in a middle-aged individual (45-year-old man),
observed within the hippocampus. Several lipid droplets of various sizes
and differing in electron densities (asterisks) can be seen in the inset (C).
Note the small size and grouped organization of several of these
droplets. (TIF 11343 kb)
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Additional file 4: Figure S3. Microglial cell morphology, phagocytosis,
and mitochondrial alterations following stimulation with LPS. A–B:
Microglial cell showing nuclear budding (arrowhead), a phenomenon
suggestive of ongoing mitosis, and an accumulation of mitochondria
with various alterations (m; inset). In particular, mitochondria partially
to completely devoid of cristae and partially to completely devoid of
a double external membrane can be seen. The adjacent microglial cell
is representative of the most frequently observed morphological phenotype
following treatment with LPS, showing several lipid vacuoles (v), similarly to
what has been described previously. er = endoplasmic reticulum. C–D:
microglial cell showing an accumulation of small mitochondria often
devoid of cristae (inset). Budding from larger mitochondria can sometimes
be seen (arrowhead). g = golgi apparatus. E–F: Microglial cell
containing mitochondria of various sizes, from small to large, and
often showing alteration (inset), as well as a large phagocytic
inclusion (in). To be noted, only mitochondria showing alteration are
annotated in the three insets. (TIF 18662 kb)
Additional file 5: Figure S4. Mitochondrial membrane potential of
microglial cells exposed to DHA. A. Change in mitochondrial membrane
potential in N9 microglial cells exposed to DHA and LPS for 6 h.
Mitochondrial membrane potential of N9 microglial cells treated with
DHA (50 μM) for 6 h. Following treatment, the cells were incubated with
TMRE (50 nM) for 20 min, after which the media was refreshed and cells
were imaged under a fluorescence microscope. Three fields were imaged
per treatment, and ten cells were imaged per field. Shown are average
fold increase in intracellular relative fluorescence intensities ± SEM as
compared to untreated control (set to 1) from two independent
experiments. *p < 0.01; **p < 0.001 B. Change in mitochondrial membrane
potential in N9 microglial cells exposed to DHA (5–50 μM) for 24 h.
Following treatment, cells were incubated with TMRE (50 nM) for 20 min,
after which the media was refreshed and cells were imaged under a
fluorescence microscope. Four fields were imaged per treatment, and
two cells were imaged per field. Shown are average fold increase in
intracellular relative fluorescence intensities ± SEM as compared to
untreated control (set to 1) from three independent experiments. Cells
imaged in the absence of TMRE and cells treated with FCCP were
negative controls. *p < 0.01. (TIF 1214 kb)
Additional file 6: Figure S5. Reduction of oxidative stress in
microglial cells treated with DHA. Oxidative stress in N9 microglial
cells following treatment with DHA (10, 25, 50 μM), in the presence
or absence of LPS (100 ng/mL) for 1 h. Hydrogen peroxide (20 μM)
was included as a positive control. N9 microglial cells were loaded
with CM-H2DCFDA (10 μM, 30 min), then exposed to treatment.
Following treatment, intracellular fluorescence was imaged in live
cells using a fluorescence microscope. Four fields were imaged per
treatment, and 30 cells were analyzed per field. Shown are average
relative intracellular fluorescence ± SEM (fold increase of control set
to 1) from three independent experiments. **p < 0.001 compared to
control; ##p < 0.001 compared to LPS. (TIF 1344 kb)
Additional file 7: Figure S6. Phagocytosis of microglial cells exposed
to BSA and LPS. Effect of BSA on N9 microglial phagocytic activity with
and without LPS. N9 microglial cells were cultured in the presence or
absence of BSA (concentration equivalent that of 25 or 50 μM DHA) and
LPS (100 ng/mL) for 24 h. FluoSpheres (106 particles/mL) were added to
the cells 3 h before the end of treatment. Cells were fixed using 4 %
paraformaldehyde and labeled with Hoechst 33258 (10 μM, 10 min).
Cells were mounted on glass slides and imaged under a fluorescence
microscope. Four fields were imaged per treatment. The number of
cells with internalized FluoSpheres was counted. Shown are average
percentages of total cells containing FluoSpheres ± SEM from three
independent experiments. (TIF 800 kb)
Additional file 8: Figure S7. Nuclear fragmentation (between
arrowheads) following treatment with LPS. n = nucleus. (TIF 8550 kb)
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